Table 1.

Clinicopathological features of the study cohort

Clinicopathological features of the immunohistochemistry cohort	Primary bladder cancer
Individuals, n	126
Gender, n (%)
Male	101 (80.2)
Female	25 (19.8)
Median age, years (range)	71 (61–77)
Grade, n (%)
Papillary, low-grade	28/126 (22.2)
Papillary, high-grade	20/126 (15.9)
Invasive, high-grade	78/126 (61.9)
Pathological Stage, n (%)a
pTa/pT1 (NMIBC)	51/123 (41.5)
pT2-4 (MIBC)	72/123 (58.5)

NMIBC non-muscle invasive bladder cancer, MIBC muscle invasive bladder cancer

^aFor 3 patients stage could not be ascertained as clinical data was missing/not available to the investigators